Main Article Content
Abstract
Tuberculosis is still a health problem that is a global burden. Indonesia is the third-ranked country in the world with the highest TB burden, and in Ambon City, there are 1296 TB sufferers. The purpose of this laboratory-based surveillance is to describe the situation of TB disease in the Ambon Class II BTKLPP service area during 2022. This activity is operational research that monitors and evaluates the results of an examination of TB specimens sent by health facilities or those taken by themselves by Ambon Class II BTKLPP officers in TB screening activities in special places. Materials and tools used in examining TB specimens include sputum, TCM GeneXpert-TB, and other supporting materials. The results of the TB specimen examination are recorded in the TB Information System (SITB), which is a TB surveillance tool used to monitor TB cases in Indonesia. The results of this activity included: of the 347 TB samples examined, 15% were drug-sensitive TB, 1% were rifampicin-resistant TB, 2% were error, and 82% were negative. The conclusion there are still drug-sensitive TB and resistant TB in the Ambon BTKLPP service area. This activity needs to be continued so that TB cases in service areas can be monitored.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
- 1. F. Isbaniah, E. Burhan, B. Y. Sinaga, D. B. Yanifitri, D. Handayani, and Harsini, Tuberkulosis Pedoman Diagnosis Dan Penatalaksanaan Di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia, 2021.
- 2. N. A. Albaihaqi, B. Burhanuddin, and V. Z. Latuconsina, “karakteristik Pasien Tuberkulosis Paru Dengan Multidrug-Resistant (TB MDR) di RSUD dr. M. Haulussy ambon tahun 2014-2018,” ppmr, vol. 2, no. 2, pp. 90–102, Jan. 2021, doi: 10.30598/pamerivol2issue2page90-102.
- 3. Kemenkes RI. 2022. Profil Kesehatan Indonesia 2021. Jakarta: Kementerian Kesehatan Republik Indonesia, 2022.
- 4. N. Hasnanisa, S. Prasetyo, and A. Burhanudin, “Evaluasi Sistem Surveilans Tuberkulosis di Dinas Kesehatan Kabupaten Banyumas Berdasarkan Pendekatan Sistem,” Bikfokes, vol. 2, no. 3, p. 167, Jul. 2022, doi: 10.51181/bikfokes.v2i3.5960.
- 5. Kemenkes RI., 2023. “TBC Akibatkan Banyak Kerugian Ekonomi – Sehat Negeriku.” https://sehatnegeriku.kemkes.go.id/baca/umum/20190319/4629770/tbc-akibatkan-banyak-kerugian-ekonomi/ (accessed Mar. 22, 2023).
- 6. Kemenkes RI., 2023. “Melalui Kegiatan INA – TIME 2022 Ke-4, Menkes Budi Minta 90% Penderita TBC Dapat Terdeteksi di Tahun 2024 – P2P Kemenkes RI.” http://p2p.kemkes.go.id/melalui-ina-time-2022-ke-4-menkes-budi-minta-90-penderita-tbc-dapat-terdeteksi-di-tahun-2024/ (accessed Jan. 18, 2023).
- 7. Kemenkes RI., 2023. “Penderita TBC di Ambon mencapai 1.296 orang - ANTARA News Ambon, Maluku.” https://ambon.antaranews.com/berita/160740/penderita-tbc-di-ambon-mencapai-1296-orang (accessed Jun. 29, 2023).
- 8. U. A.-Q. Bayan, E. S. D. Prihanto, and M. Anwar, “karakteristik Pasien Tuberkulosis Resistan Obat Di RSUD dr. H. Chasan boesoirie,” vol. 4, 2022.
- 9. Kemenkes RI. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resisten Obat. Jakarta: Kementerian Kesehatan Republik Indonesia Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, 2020.
- 10. Tim TCM BBKPM Bandung, “Tes Cepat Molekuler (TCM) Revolusi Diagnosis TBC Sensitif Obat (TB-SO) dan TBC Kebal Obat (TB-RO),” 2019.
- http://bbkpm-bandung.org/blog/2019/04/TESCEPATMOLEKULER (accessed Jan. 11, 2021).
- 11. P. Santoso, “TBC sensitif dan TBC Resistan Obat (TBC RO),” 2021. [Online]. Available: https://www.indonesiajournalchest.com/index.php/IJC/issue/view/197/TBC%20%20sensitif%20dan%20TBC%20%20Resistan%20Obat%20%28TBC%20RO%29
- 12. D. K. Nugrahaeni, “Analisis Penyebab Resistensi Obat Anti Tuberkulosis,” Kemas, 11(1): 8, Sep. 2015, doi: 10.15294/kemas.v11i1.3341.